Open Access Research article

Trends in incidence and outcomes of revision total hip arthroplasty in Spain: A population based study

Manuel Villanueva-Martınez1, Valentın Hernandez-Barrera2, Francisco Chana-Rodríguez1, José Rojo-Manaute1, Antonio Rıos-Luna3, Jesus San Roman Montero2, Angel Gil-de-Miguel2 and Rodrigo Jimenez-Garcıa2*

Author Affiliations

1 Orthopedic Department, Hospital Gregorio Marañon, Madrid, Spain

2 Preventive Medicine and Public Health Teaching and Research Unit, Department of Health Sciences, Universidad Rey Juan Carlos, Madrid, Spain

3 Orthopedic Department, Virgen del Mar Hospital, Almeria, Spain

For all author emails, please log on.

BMC Musculoskeletal Disorders 2012, 13:37  doi:10.1186/1471-2474-13-37

Published: 19 March 2012



To analyze changes in incidence and outcomes of patients undergoing revision total hip arthroplasty (RTHA) over an 8-year study period in Spain.


We selected all surgical admissions in individuals aged ≥ 40 years who underwent RTHA (ICD-9-CM procedure code 81.53) between 2001 and 2008 from the Spanish National Hospital Discharge Database. Age- and sex-specific incidence rates, Charlson co-morbidity index, length of stay (LOS), costs and in-hospital mortality (IHM) were estimated for each year. Multivariate analyses were conducted to asses time trends.


32, 280 discharges of patients (13, 391 men/18, 889 women) having undergone RTHA were identified. Overall crude incidence showed a small but significant increase from 20.2 to 21.8 RTHA per 100, 000 inhabitants from 2001 to 2008 (p < 0.01).

The incidence increased for men (17.7 to 19.8 in 2008) but did not vary for women (22.3 in 2001 and 22.2 in 2008). Greater increments were observed in patients older than 84 years and in the age group 75-84. In 2001, 19% of RTHA patients had a Charlson Index ≥ 1 and this proportion rose to 24.6% in 2008 (p < 0.001). The ratio RTHA/THA remained stable and around 20% in Spain along the entire period

The crude overall in-hospital mortality (IHM) increased from 1.16% in 2001 to 1.77% (p = 0.025) in 2008. For both sexes the risk of death was higher with age, with the highest mortality rates found among those aged 85 or over. After multivariate analysis no change was observed in IHM over time. The mean inflation adjusted cost per patient increased by 78.3%, from 9, 375 to 16, 715 Euros from 2001 to 2008.

After controlling for possible confounders using Poisson regression models, we observed that the incidence of RTHA hospitalizations significantly increased for men and women over the period 2001 to 2008 (IRR 1.10, 95% CI 1.03-1.18 and 1.08, 95% CI 1.02-1.14 respectively).


The crude incidence of RTHA in Spain showed a small but significant increase from 2001 to 2008 with concomitant reductions in LOS, significant increase in co-morbidities and cost per patient.

Revision; Hip arthroplasty; Cost; Mortality; Outcome research; Osteoarthritis; Revision; Hospital; Charlson Index; Discharge Database